WallStreetZenWallStreetZen

NASDAQ: CORT
Corcept Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Corcept Therapeutics earnings were $139.7M for the trailing 12 months ending Dec 31, 2024, with 32.4% growth year over year. The latest CORT earnings report on Dec 31, 2024 announced Q4 2024 earnings of $30.4M, down 34.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CORT reported annual earnings of $139.7M, with 32.5% growth. The next CORT earnings date is Apr 29, 2025.

CORT past earnings growth

How has CORT's earnings growth performed historically?

Company
32.35%
Industry
12%
Market
64.06%
CORT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
CORT's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
CORT's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

CORT earnings history

Current Revenue
$675.0M
Current Earnings
$139.7M
Current Profit Margin
20.7%

CORT Return on Equity

Current Company
22.7%
Current Industry
-1.7%
Current Market
34.2%
CORT's Return on Equity (22.7%)... subscribe to Premium to read more.
High Return on Equity Performance

CORT undefined

Current Company
18.7%
Current Industry
0%
CORT is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CORT announces earnings.

CORT undefined

Current Company
19.36%
Current Industry
6.4%
CORT's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CORT vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CORT$136.81M$139.73M+10.49%$1.35
AXSM-$271.22M-$287.22MN/A-$5.99
TLX$58.49M$31.40MN/AN/A
BPMC-$11.50M-$67.09MN/A-$1.07
TGTX$49.69M$23.38M+77.78%$0.16
View Top Biotech Stocks

CORT earnings dates

Next earnings date
Apr 29, 2025

Corcept Therapeutics Earnings Reports & History FAQ

What were Corcept Therapeutics's earnings last quarter?

On CORT's earnings call on Invalid Date, Corcept Therapeutics (NASDAQ: CORT) reported Q4 2024 earnings per share (EPS) of $0.29, up 3.33% year over year. Total CORT earnings for the quarter were $30.39 million. In the same quarter last year, Corcept Therapeutics's earnings per share (EPS) was $0.30.

If you're new to stock investing, here's how to buy Corcept Therapeutics stock.

When does Corcept Therapeutics report earnings?

The next CORT earnings call is Invalid Date. Add CORT to your watchlist to be reminded of Corcept Therapeutics's next earnings date.

What was CORT's earnings growth in the past year?

As of Corcept Therapeutics's earnings date in Invalid Date, Corcept Therapeutics's earnings has grown 32.35% year over year. This is 20.35 percentage points higher than the US Biotechnology industry earnings growth rate of 12%. CORT earnings in the past year totalled $139.73 million.

Is Corcept Therapeutics profitable or losing money?

As of the last Corcept Therapeutics earnings report, Corcept Therapeutics is currently profitable. Corcept Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $139.73 million, a 32.45% increase year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.